Schmidt-Rohlfing B, Tzioupis C, Menzel C L, Pape H C
Klinik für Orthopädie und Unfallchirurgie, Schwerpunkt Unfallchirurgie, Universitätsklinikum der RWTH Aachen.
Unfallchirurg. 2009 Sep;112(9):785-94; quiz 795. doi: 10.1007/s00113-009-1695-x.
Complex fractures are still a major clinical challenge. The treatment options of large bony defects either with autografts or allografts are limited in terms of material availability and tissue in-growth. Tissue engineering might offer a solution to this problem. In an interdisciplinary approach artificial bony tissue can be generated which mimics normal bone in terms of function and morphology. So far tissue engineering of bone is mainly confined to laboratory investigations whereas clinical applications are still in the beginning. This manuscript presents the most important scaffolds as well as growth factors and cell systems. Furthermore, it focuses on clinical studies for the treatment of large bony defects using tissue engineered cell-matrix constructs.
复杂骨折仍然是一个重大的临床挑战。无论是使用自体骨移植还是异体骨移植来治疗大的骨缺损,在材料可用性和组织向内生长方面,治疗选择都很有限。组织工程可能为这个问题提供解决方案。通过跨学科方法,可以生成在功能和形态上模仿正常骨骼的人工骨组织。到目前为止,骨组织工程主要局限于实验室研究,而临床应用仍处于起步阶段。本文介绍了最重要的支架以及生长因子和细胞系统。此外,它还专注于使用组织工程化细胞 - 基质构建体治疗大骨缺损的临床研究。